Predictors of post-operative cardiovascular complications for Behçet's disease with pre-operative immunosuppressive therapy
Pre-operative immunosuppressive therapy is vital for BD patients. Monitoring inflammatory biomarkers helps identify the best timing for surgery and reduces complications.
Authors
- Hongkun Qing
- Xuhua Jian
- Lanxin Ye
- Fanyu Chen (ORCID: https://orcid.org/0000-0002-1102-2534)
- Weiteng Wang (ORCID: https://orcid.org/0000-0001-6480-9325)
- Lixi Gan
- Oudi Chen (ORCID: https://orcid.org/0000-0002-9069-6683)
- Zhuang Li (ORCID: https://orcid.org/0000-0002-6938-1177)
- Yang Cui
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Fu Wai Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-10-23
- DOI
- https://doi.org/10.55563/clinexprheumatol/gkx830
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00